The DOI matches its Crossref record.
Opportunities and responsibilities in pharmaceutical care
Abstract
Pharmacy's opportunity to mature as a profession by accepting its social responsibility to reduce preventable drug-related morbidity and mortality is explored. Pharmacy has shed the apothecary role but has not yet been restored to its erst-while importance in medical care. It is not enough to dispense the correct drug or to provide sophisticated pharmaceutical services; nor will it be sufficient to devise new technical functions. Pharmacists and their institutions must stop looking inward and start redirecting their energies to the greater social good. Some 12,000 deaths and 15,000 hospitalizations due to adverse drug reactions (ADRs) were reported to the FDA in 1987, and many went unreported. Drug-related morbidity and mortality are often preventable, and pharmaceutical services can reduce the number of ADRs, the length of hospital stays, and the cost of care. Pharmacists must abandon factionalism and adopt patient-centered pharmaceutical care as their philosophy of practice. Changing the focus of practice from products and biological systems to ensuring the best drug therapy and patient safety will raise pharmacy's level of responsibility and require philosophical, organizational, and functional changes. It will be necessary to set new practice standards, establish cooperative relationships with other health-care professions, and determine strategies for marketing pharmaceutical care. Pharmacy's reprofessionalization will be completed only when all pharmacists accept their social mandate to ensure the safe and effective drug therapy of the individual patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model
Ernst, F. R., & Grizzle, A. J. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31229-3 · Cited by 849
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Hanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., Cowper, P. A., Landsman, P. B., Cohen, H. J., & Feussner, J. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89519-8 · Cited by 612
Drug-Related Problems: Their Structure and Function
Strand, L. M., Morley, P. C., Cipolle, R. J., Ramsey, R., & Lamsam, G. D. (1990) · DICP · doi:10.1177/106002809002401114 · Cited by 569
Self-citationConstellations of Institutional Logics: Changes in the Professional Work of Pharmacists
Goodrick, E., & Reay, T. (2011) · Work and Occupations · doi:10.1177/0730888411406824 · Cited by 543
Interventions to improve the appropriate use of polypharmacy for older people
Rankin, A., Cadogan, C. A., Patterson, S. M., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub4 · Cited by 511
Burns, A. (2008) · Journal of the American Pharmacists Association · doi:10.1331/japha.2008.08514 · Cited by 477
Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., Noyce, P., & Sketris, I. (2015) · Health Policy · doi:10.1016/j.healthpol.2015.02.007 · Cited by 465
Economic analysis of the prevalence and clinical and economic burden of medication error in England
Elliott, R. A., Camacho, E., Jankovic, D., Sculpher, M. J., & Faria, R. (2021) · BMJ Quality & Safety · doi:10.1136/bmjqs-2019-010206 · Cited by 425
ASHP Guidelines on Preventing Medication Errors in Hospitals
Billstein-Leber, M., Carrillo, C. J. D., Cassano, A. T., Moline, K., & Robertson, J. J. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp170811 · Cited by 398
Thomsen, L. A., Winterstein, A. G., S⊘ndergaard, B., Haugb⊘lle, L. S., & Melander, A. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h658 · Cited by 393
Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k311 · Cited by 378
Cost of Prescription Drug–Related Morbidity and Mortality
Watanabe, J. H., McInnis, T., & Hirsch, J. D. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018765159 · Cited by 365
Reduction of Polypharmacy in the Elderly: A Systematic Review of the Role of the Pharmacist
Rollason, V., & Vogt, N. (2003) · Drugs & Aging · doi:10.2165/00002512-200320110-00003 · Cited by 361
Cooper, J. A., Cadogan, C. A., Patterson, S. M., Kerse, N., Bradley, M. C., Ryan, C., & Hughes, C. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009235 · Cited by 344
Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System
de Oliveira, D. R., Brummel, A. R., & Miller, D. B. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.9.1057 · Cited by 317
Evaluation of a Pharmaceutical Care Model on Diabetes Management
Jaber, L. A., Halapy, H., Fernet, M., Tummalapalli, S., & Diwakaran, H. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000305 · Cited by 313
Zed, P. J., Abu-Laban, R. B., Balen, R. M., Loewen, P. S., Hohl, C. M., Brubacher, J. R., Wilbur, K., Wiens, M. O., Samoy, L. J., Lacaria, K., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071594 · Cited by 311
Kretchy, I. A., Asiedu-Danso, M., & Kretchy, J.-P. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.007 · Cited by 301
Tsuyuki, R. T. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1149 · Cited by 290
Deprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications
Woodward, M. C. (2003) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr2003334323 · Cited by 287
Milosavljevic, A., Aspden, T., & Harrison, J. (2018) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12462 · Cited by 266
The Health Care Cost of Drug-Related Morbidity and Mortality in Nursing Facilities
Bootman, J. L. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440390083011 · Cited by 259
PCNE definition of medication review: reaching agreement
Griese-Mammen, N., Hersberger, K. E., Messerli, M., Leikola, S., Horvat, N., van Mil, J. W. F., & Kos, M. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0696-7 · Cited by 259
The role of pharmacists in developing countries: the current scenario in Pakistan
Azhar, S., Hassali, M. A., Ibrahim, M. I. M., Ahmad, M., Masood, I., & Shafie, A. A. (2009) · Human Resources for Health · doi:10.1186/1478-4491-7-54 · Cited by 253
George, J., Elliott, R. A., & Stewart, D. C. (2008) · Drugs & Aging · doi:10.2165/00002512-200825040-00004 · Cited by 191
Pousinho, S., Morgado, M., Falcão, A., & Alves, G. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.5.493 · Cited by 199
Mil, J. W. F., Schulz, M., & Tromp, T. F. J. D. (2004) · Pharmacy World & Science · doi:10.1007/s11096-004-2849-0 · Cited by 145
Transitions, part 1: beyond pharmaceutical care
Holland, R. W., & Nimmo, C. M. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.17.1758 · Cited by 146
Mehuys, E., Van Bortel, L., De Bolle, L., Van Tongelen, I., Annemans, L., Remon, J.-P., & Giri, M. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01218.x · Cited by 139
“has included pharmacist cooperation in diabetes management, in-line with greater involvement of the pharmacy profession in patient-oriented activities (4, 5).”
Backgroundvan Eikenhorst, L., Taxis, K., van Dijk, L., & de Gier, H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00891 · Cited by 121
“This is all the more important because of the still ongoing paradigm shift of the role of the pharmacist from being a drug supplier to a drug therapymanager (Hepler and Strand, 1990; Wiedenmayer et al., 2006).”
BackgroundClinton-McHarg, T., Yoong, S. L., Tzelepis, F., Regan, T., Fielding, A., Skelton, E., Kingsland, M., Ooi, J. Y., & Wolfenden, L. (2016) · Implementation Science · doi:10.1186/s13012-016-0512-5 · Cited by 116
Independent Pharmacist Prescribing in Canada
Law, M. R., Ma, T., Fisher, J., & Sketris, I. S. (2012) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.3821/1913-701x-145.1.17 · Cited by 107
Mossialos, E., Naci, H., & Courtin, E. (2013) · Health Policy · doi:10.1016/j.healthpol.2013.04.003 · Cited by 104
“All authors eviewed and discussed the identified materials to comile a comprehensive list of community pharmacist roles nd responsibilities, documented to broadly parallel the omains of Total Pharmaceutical Care [8] and Pharmaeutical Care models [7].”
Pharmacists' perceptions of professionalism on social networking sites
Benetoli, A., Chen, T. F., Schaefer, M., Chaar, B., & Aslani, P. (2017) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2016.05.044 · Cited by 25
“However, pharmacy has since undergone considerable change, particularly in the last two decades.(14,15) There is a paucity of literature on pharmacy professionalism, with much of what exists focusing on pharmacy students.”
Backgroundvan de Steeg-van Gompel, C. H. P. A., Wensing, M., & De Smet, P. A. G. M. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.07.009 · Cited by 19
Sakthong, P., Soipitak, P., & Winit-Watjana, W. (2024) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01692-9 · Cited by 7
Hartnell, N. R., MacKinnon, N. J., Sketris, I. S., & Gass, D. (2005) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/171516350513800611 · Cited by 4
Metadata
- Authors
- Hepler, C. D., & Strand, L. M.
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-03-01
- Volume
- 47
- Issue
- 3
- Pages
- 533-543
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W2113847478
- Cited by
- 2,895
- References
- 0
- FWCI
- 16.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.